Skip to main content
. 2009 Nov 9;24(6):1158–1164. doi: 10.3346/jkms.2009.24.6.1158

Fig. 1.

Fig. 1

c-erbB2 immunohistochemical analysis. (A) 1+, faint (×100); (B) 2+, weak to moderate complete membranous (×200); (C) 3+, strong and complete membranous (×400); and (D) 3+, strong basalateral membranous reactivities (×400).